A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera
Clinical trial NCT05143957 · COMPLETED
Trial details
- NCT number
- NCT05143957
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2025-06-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.